All In Biotech

Free tool

FAERS Monitor: Denavir

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020629 or its brand name (Denavir, Penciclovir). Reports on generic versions are filed under their own applications.

Reports

362

Serious

217

60% of reports

Hospitalization

93

Death reported

24

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective46
  • headache31
  • fatigue28
  • pain26
  • diarrhoea25
  • hypertension22
  • chronic kidney disease20
  • cough20
  • vomiting20
  • anaemia18
  • condition aggravated18
  • nausea18
  • back pain17
  • anxiety16
  • depression16

Reports by year received

View as table
YearReports
20048
20056
200611
200710
20086
20099
201010
201114
201210
201313
20148
201527
201649
201728
201831
201932
202020
202116
202218
20239
20248
20258
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,797 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal2015.310.0254
hypertensionSignal226.04.088
anaemiaSignal185.53.562
back painSignal174.32.740
coughSignal204.12.745
depressionSignal164.12.535
condition aggravatedSignal183.42.229
anxietySignal163.32.023
headacheSignal312.92.137
vomitingSignal202.51.616
painSignal262.51.722
diarrhoeaSignal252.31.517
fatigueSignal282.11.515
drug ineffectiveSignal462.01.524
nausea181.30.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.